The National Institute of Allergy and Infectious Diseases (NIAID) is offering this Investigator-Initiated Program Project (P01) grant. This grant is for supporting synergistic research addressing scientific areas relevant to NIAID’s mission. Specifically, it targets research into the biology and pathogenesis of infectious microbes, including HIV, host-microbe interactions, and the regulation and dysfunction of the immune system leading to conditions like allergy, autoimmunity, or immunodeficiency. Furthermore, it encourages translational research to develop vaccines, therapeutics, and diagnostics for infectious and immune-mediated diseases. Each application must include at least two related research projects sharing a central theme and an administrative core, with optional scientific cores.
Opportunity ID: 343474
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-22-225 |
| Funding Opportunity Title: | NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Sep 13, 2022 |
| Last Updated Date: | Sep 13, 2022 |
| Original Closing Date for Applications: | Sep 07, 2025 |
| Current Closing Date for Applications: | Sep 07, 2025 |
| Archive Date: | Oct 13, 2025 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Native American tribal governments (Federally recognized) City or township governments Public and State controlled institutions of higher education Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments Public housing authorities/Indian housing authorities State governments Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) invites submission of investigator-initiated Program Project (P01) applications. The proposed programs should address scientific areas relevant to the NIAID mission including: biology and pathogenesis of infectious microbes, including HIV; host-microbe interactions; mechanisms regulating immune system development and function across the lifespan, and in response to infectious pathogens; immune dysfunction resulting in allergy, asthma, autoimmunity, immunodeficiency, or transplant rejection; and translational research to develop vaccines, therapeutics, and diagnostics to prevent and treat infectious and immune-mediated diseases. Each P01 application submitted to this FOA must include at least two related, synergistic research projects that share a common central theme, focus, and/or overall objective; and an administrative core. A P01 may include scientific cores, if needed for the proposed research. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/pa-files/PAR-22-225.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 343474 Full Announcement-PAR-22-225 -> PAR-22-225-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00276791 | Dec 11, 2022 | Jan 24, 2023 | View | |
| FORMS-H | Use for due dates on or before January 24, 2025 | PKG00277503 | Dec 11, 2022 | Jan 24, 2025 | View | |
| FORMS-I | Use for due dates on or after January 25, 2025 | PKG00289295 | Dec 02, 2024 | Sep 07, 2025 | View |
Package 1
Mandatory forms
343474 RR_SF424_5_0-5.0.pdf
343474 PHS398_CoverPageSupplement_5_0-5.0.pdf
343474 RR_OtherProjectInfo_1_4-1.4.pdf
343474 PerformanceSite_4_0-4.0.pdf
343474 RR_KeyPersonExpanded_4_0-4.0.pdf
343474 PHS398_ResearchPlan_5_0-5.0.pdf
343474 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
343474 PHS_Additional_IndirectCosts_2_0-2.0.pdf
343474 PHS_AssignmentRequestForm_4_0-4.0.pdf
Package 2
Mandatory forms
343474 RR_SF424_5_0-5.0.pdf
343474 PHS398_CoverPageSupplement_5_0-5.0.pdf
343474 RR_OtherProjectInfo_1_4-1.4.pdf
343474 PerformanceSite_4_0-4.0.pdf
343474 RR_KeyPersonExpanded_4_0-4.0.pdf
343474 PHS398_ResearchPlan_4_0-4.0.pdf
343474 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
343474 PHS_Additional_IndirectCosts_2_0-2.0.pdf
343474 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
343474 RR_SF424_5_0-5.0.pdf
343474 PHS398_CoverPageSupplement_5_0-5.0.pdf
343474 RR_OtherProjectInfo_1_4-1.4.pdf
343474 PerformanceSite_4_0-4.0.pdf
343474 RR_KeyPersonExpanded_4_0-4.0.pdf
343474 PHS398_ResearchPlan_5_0-5.0.pdf
343474 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
343474 PHS_Additional_IndirectCosts_2_0-2.0.pdf
343474 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
